Daiichi Sankyo Company, Limited - Product Pipeline Review - 2015

  • ID: 3440602
  • Company Profile
  • 181 pages
  • Global Markets Direct
  • Daiichi Sankyo Co Ltd
1 of 4
Daiichi Sankyo Company, Limited - Product Pipeline Review - 2015

Summary

The report ‘Daiichi Sankyo Company, Limited - Product Pipeline Review - 2015’, provides an overview of the Daiichi Sankyo Company, Limited’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Daiichi Sankyo Company, Limited’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updates following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Daiichi Sankyo Company, Limited including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Daiichi Sankyo Company, Limited’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Daiichi Sankyo Company, Limited’s pipeline products

Reasons to buy

- Evaluate Daiichi Sankyo Company, Limited’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Daiichi Sankyo Company, Limited in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Daiichi Sankyo Company, Limited’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Daiichi Sankyo Company, Limited and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Daiichi Sankyo Company, Limited
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Daiichi Sankyo Company, Limited and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Daiichi Sankyo Company, Limited Snapshot

Daiichi Sankyo Company, Limited Overview

Key Information

Key Facts

Daiichi Sankyo Company, Limited - Research and Development Overview

Key Therapeutic Areas

Daiichi Sankyo Company, Limited - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Partnered Products

Pipeline Products - Out-Licensed Products

Daiichi Sankyo Company, Limited - Pipeline Products Glance

Daiichi Sankyo Company, Limited - Late Stage Pipeline Products

Daiichi Sankyo Company, Limited - Clinical Stage Pipeline Products

Daiichi Sankyo Company, Limited - Early Stage Pipeline Products

Daiichi Sankyo Company, Limited - Drug Profiles

edoxaban tosylate

levofloxacin

VN-100

CL-108

denosumab

etanercept biosimilar

hydromorphone hydrochloride

KIB-PCI

mirogabalin besylate

nimotuzumab

patritumab

prasugrel hydrochloride

quizartinib dihydrochloride

tivantinib

VN-0103

CS-3150

DS-8500

efatutazone

laninamivir

AC-410

DS-1040

DS-1093

DS-1150b

DS-1501

DS-1971

DS-3032

DS-3801

DS-5573a

DS-6051

DS-7080a

DS-8201a

DS-8273

DS-8312

DS-8895

DY-807f

Small Molecule to Inhibit Ubiquitin Ligase for Cancer

U3-1565

AC-014

AC-081

AC-708

CS-1050

DC-159a

DF-461

DS-1558

DS-8108b

Monoclonal Antibodies for Undisclosed Indication

PN1-Ab

Protein for Undiscosed Indication

Recombinant Proteins 2 for Undisclosed Indication

Small Molecule for Respiratory Tract Infections

Small Molecule To Agonize Liver X Receptor for Atherosclerosis

Small Molecule to Agonize PPAR Alpha and PPAR Gamma for Metabolic Disorders

Small Molecule to Agonize PPAR Gamma Receptor for Type 2 Diabetes

Small Molecule to Inhibit I-KappaB Kinase Beta for Rheumatoid Arthritis

Small Molecule to Inhibit PDE4 for COPD

Small Molecule to Inhibit PDE4B for Lung Inflammation

Small Molecule to Inhibit Renin for Hypertension

Small Molecule to Inhibit SCD-1 for Nonalcoholic Steatohepatitis

Small Molecule to Inhibit VLA-4 for Asthma

Small Molecules to Inhibit FATP1 for Undisclosed Indication

Small Molecules to Inhibit p53-MDM2 Interaction for Cancer

SQ-641

U3-1784

Antisense Oligonucleotide for Duchenne Muscular Dystrophy

Drugs for Cancer

Drugs for Oncology, Cardiovascular and Metabolic Diseases

DS-5272

Pedopeptins to Inhibit LPS for Bacterial Infection

Small Molecule for Cardiovascular-Metabolic Diseases

Small Molecule for Tuberculosis

Small Molecule to Inhibit CTP synthase for Respiratory Tract Infections

Small Molecules for Malaria

Small Molecules for Multiple Neurodegenerative Diseases

Small Molecules for Osteopenia and Osteoporosis

Small Molecules to Agonize BRS-3 for Obesity

Sphaerimicin A

U-31201

U-31910

U-31987

Daiichi Sankyo Company, Limited - Pipeline Analysis

Daiichi Sankyo Company, Limited - Pipeline Products by Target

Daiichi Sankyo Company, Limited - Pipeline Products by Route of Administration

Daiichi Sankyo Company, Limited - Pipeline Products by Molecule Type

Daiichi Sankyo Company, Limited - Pipeline Products by Mechanism of Action

Daiichi Sankyo Company, Limited - Recent Pipeline Updates

Daiichi Sankyo Company, Limited - Dormant Projects

Daiichi Sankyo Company, Limited - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

Daiichi Sankyo Company, Limited - Company Statement

Daiichi Sankyo Company, Limited - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Daiichi Sankyo Company, Limited - Key Manufacturing Facilities

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Daiichi Sankyo Company, Limited, Key Information

Daiichi Sankyo Company, Limited, Key Facts

Daiichi Sankyo Company, Limited - Pipeline by Indication, 2015

Daiichi Sankyo Company, Limited - Pipeline by Stage of Development, 2015

Daiichi Sankyo Company, Limited - Monotherapy Products in Pipeline, 2015

Daiichi Sankyo Company, Limited - Partnered Products in Pipeline, 2015

Daiichi Sankyo Company, Limited - Partnered Products/ Combination Treatment Modalities, 2015

Daiichi Sankyo Company, Limited - Out-Licensed Products in Pipeline, 2015

Daiichi Sankyo Company, Limited - Out-Licensed Products/ Combination Treatment Modalities, 2015

Daiichi Sankyo Company, Limited - Pre-Registration, 2015

Daiichi Sankyo Company, Limited - Filing rejected/Withdrawn, 2015

Daiichi Sankyo Company, Limited - Phase III, 2015

Daiichi Sankyo Company, Limited - Phase II, 2015

Daiichi Sankyo Company, Limited - Phase I, 2015

Daiichi Sankyo Company, Limited - Preclinical, 2015

Daiichi Sankyo Company, Limited - Discovery, 2015

Daiichi Sankyo Company, Limited - Pipeline by Target, 2015

Daiichi Sankyo Company, Limited - Pipeline by Route of Administration, 2015

Daiichi Sankyo Company, Limited - Pipeline by Molecule Type, 2015

Daiichi Sankyo Company, Limited - Pipeline Products by Mechanism of Action, 2015

Daiichi Sankyo Company, Limited - Recent Pipeline Updates, 2015

Daiichi Sankyo Company, Limited - Dormant Developmental Projects,2015

Daiichi Sankyo Company, Limited - Discontinued Pipeline Products, 2015

Daiichi Sankyo Company, Limited, Subsidiaries

Daiichi Sankyo Company, Limited, Key Manufacturing Facilities

List of Figures

Daiichi Sankyo Company, Limited - Pipeline by Top 10 Indication, 2015

Daiichi Sankyo Company, Limited - Pipeline by Stage of Development, 2015

Daiichi Sankyo Company, Limited - Monotherapy Products in Pipeline, 2015

Daiichi Sankyo Company, Limited - Partnered Products in Pipeline, 2015

Daiichi Sankyo Company, Limited - Pipeline by Top 10 Target, 2015

Daiichi Sankyo Company, Limited - Pipeline by Top 10 Route of Administration, 2015

Daiichi Sankyo Company, Limited - Pipeline by Top 10 Molecule Type, 2015

Daiichi Sankyo Company, Limited - Pipeline Products by Top 10 Mechanism of Action, 2015
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll